These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 9764818

  • 1. Grb2 binding to the different isoforms of Ret tyrosine kinase.
    Alberti L, Borrello MG, Ghizzoni S, Torriti F, Rizzetti MG, Pierotti MA.
    Oncogene; 1998 Sep 03; 17(9):1079-87. PubMed ID: 9764818
    [Abstract] [Full Text] [Related]

  • 2. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
    Besset V, Scott RP, Ibáñez CF.
    J Biol Chem; 2000 Dec 15; 275(50):39159-66. PubMed ID: 10995764
    [Abstract] [Full Text] [Related]

  • 3. Key role of Shc signaling in the transforming pathway triggered by Ret/ptc2 oncoprotein.
    Mercalli E, Ghizzoni S, Arighi E, Alberti L, Sangregorio R, Radice MT, Gishizky ML, Pierotti MA, Borrello MG.
    Oncogene; 2001 Jun 14; 20(27):3475-85. PubMed ID: 11429694
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease.
    Carlomagno F, Melillo RM, Visconti R, Salvatore G, De Vita G, Lupoli G, Yu Y, Jing S, Vecchio G, Fusco A, Santoro M.
    Endocrinology; 1998 Aug 14; 139(8):3613-9. PubMed ID: 9681515
    [Abstract] [Full Text] [Related]

  • 6. Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction.
    Kurokawa K, Iwashita T, Murakami H, Hayashi H, Kawai K, Takahashi M.
    Oncogene; 2001 Apr 12; 20(16):1929-38. PubMed ID: 11360177
    [Abstract] [Full Text] [Related]

  • 7. The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma.
    Borrello MG, Alberti L, Arighi E, Bongarzone I, Battistini C, Bardelli A, Pasini B, Piutti C, Rizzetti MG, Mondellini P, Radice MT, Pierotti MA.
    Mol Cell Biol; 1996 May 12; 16(5):2151-63. PubMed ID: 8628282
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site.
    Geneste O, Bidaud C, De Vita G, Hofstra RM, Tartare-Deckert S, Buys CH, Lenoir GM, Santoro M, Billaud M.
    Hum Mol Genet; 1999 Oct 12; 8(11):1989-99. PubMed ID: 10484767
    [Abstract] [Full Text] [Related]

  • 10. Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells.
    Hennige AM, Lammers R, Arlt D, Höppner W, Strack V, Niederfellner G, Seif FJ, Häring HU, Kellerer M.
    Mol Cell Endocrinol; 2000 Sep 25; 167(1-2):69-76. PubMed ID: 11000521
    [Abstract] [Full Text] [Related]

  • 11. Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation.
    Kawai K, Iwashita T, Murakami H, Hiraiwa N, Yoshiki A, Kusakabe M, Ono K, Iida K, Nakayama A, Takahashi M.
    Cancer Res; 2000 Sep 15; 60(18):5254-60. PubMed ID: 11016655
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade.
    Melillo RM, Santoro M, Ong SH, Billaud M, Fusco A, Hadari YR, Schlessinger J, Lax I.
    Mol Cell Biol; 2001 Jul 15; 21(13):4177-87. PubMed ID: 11390647
    [Abstract] [Full Text] [Related]

  • 15. Shc and Enigma are both required for mitogenic signaling by Ret/ptc2.
    Durick K, Gill GN, Taylor SS.
    Mol Cell Biol; 1998 Apr 15; 18(4):2298-308. PubMed ID: 9528800
    [Abstract] [Full Text] [Related]

  • 16. The oncogenic versions of the Ret and Trk tyrosine kinases bind Shc and Grb2 adaptor proteins.
    Borrello MG, Pelicci G, Arighi E, De Filippis L, Greco A, Bongarzone I, Rizzetti M, Pelicci PG, Pierotti MA.
    Oncogene; 1994 Jun 15; 9(6):1661-8. PubMed ID: 8183561
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A mutation at tyrosine 1062 in MEN2A-Ret and MEN2B-Ret impairs their transforming activity and association with shc adaptor proteins.
    Asai N, Murakami H, Iwashita T, Takahashi M.
    J Biol Chem; 1996 Jul 26; 271(30):17644-9. PubMed ID: 8663426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.